🔎 Trials Near Me

Home › Lymphoma › Nebraska

Pag-aaral pangklinika para sa Lymphoma sa Nebraska

7 pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa mga site sa Nebraska.

Mga Lungsod sa Nebraska

Opisyal na teksto ng pag-aaral (English)

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • University of Nebraska Medical Center, Omaha
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

  • University of Nebraska Medical Center, Omaha
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT04898790

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

  • University of Nebraska Medical Center, Omaha
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT06528301

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • University of Nebraska Medical Center (UNMC), Omaha
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy

  • Unversity of Nebraska Medical Center, Omaha
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05135351

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Fred and Pamela Buffett Cancer Center, Omaha
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
Nagre-recruitPhase 1/2
Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.